ArriVent BioPharma, Inc. AVBP Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s current ratio?
- ArriVent BioPharma, Inc. (AVBP) reported current ratio of 14× in Q1 2026.
- How has ArriVent BioPharma, Inc.'s current ratio changed year-over-year?
- ArriVent BioPharma, Inc.'s current ratio decreased by 2.7% year-over-year, from 14.3× to 14×.
- What is the long-term trend for ArriVent BioPharma, Inc.'s current ratio?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s current ratio has grown at a -3.4% compound annual growth rate (CAGR), from 13.8× to 12.8×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.